Ginkgo & OpenAI Slash Protein Synthesis Costs by 40%
Ginkgo Bioworks teams up with OpenAI to cut cell-free protein synthesis costs by 40% using AI and cloud lab automation.
Already have an account? Sign in.
Ginkgo Bioworks teams up with OpenAI to cut cell-free protein synthesis costs by 40% using AI and cloud lab automation.
Nike innovation chief leaves after less than a year amid falling sales, China struggles, and faster rivals; company reshuffles leadership.
Commvault may be sold as buyers show interest. Stock down on AI fears but revenue growing; Thoma Bravo among potential bidders.
FDA again rejects Replimune’s skin cancer drug RP1, saying studies don’t prove it works; shares halted, setback for company.